Skip to main content
. 2008 Oct 8;2(1):75–79. doi: 10.1111/j.1752-8062.2008.00052.x

Figure 1.

Figure 1

FACS characterization of electrofusion product. Fusion efficiency was evaluated by flow cytometry measuring the percentage of double positive cells expressing both gp 100 (tumor cell marker) and CD11 b (DC marker). A representative FACS plot is shown. Fusion efficiencies ranged from 5% to 20%.